All In Biotech

Drug Trial Radar · NCT05372718

Thrombolysis With Recombinant Non-immunogenic Staphylokinase vs Surgery in Patients With Acute Limb Ischemia FORAT Trial

Multicenter, Open-label, Randomized Clinical Trial of Efficacy and Safety of the Thrombolysis With Recombinant Non-immunogenic Staphylokinase (Fortelyzin®) in Patients With ALI vs Surgery

Last checked: Nov 20, 2026Latest source record: Oct 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 170 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

170

Actual

Start

Dec 26, 2022

Primary completion

Sep 30, 2026

Study completion Sep 30, 2026

Sponsor

Lead sponsor
Supergene, LLCIndustry
Sponsor type
Industry
First posted
May 13, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Objective: to evaluate the efficacy and safety of intra-arterial intrathrombus administration of the recombinant non-immunogenic staphylokinase (Fortelyzin®) in patients with acute limb ischemia (ALI) vs surgery.

Conditions

  • Acute Limb Ischemia

Interventions

  • Recombinant non-immunogenic staphylokinase (Fortelyzin®)Drug

    lyophilisate for preparation a solution

  • surgical methods of treatmentProcedure

    Endovascular intervention, open surgery and/or bypass surgery in accordance with the current National Guidelines

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of patients without amputationsTime frame: 30 days post randomization

Locations

8 sites in 1 country. Site status is shown where the registry gives one.

  • Kaliningrad Regional Clinical Hospital

    Kaliningrad, Russia

  • Kazan City Hospital No. 7

    Kazan', Russia

  • S.S. Yudin City clinical hospital

    Moscow, Russia

  • S.P. Botkin Moscow Multidisciplinary Scientific and Clinical Center

    Moscow, Russia

  • Ufa Emergency City Hospital

    Ufa, Russia

  • Volgograd City Clinical Hospital of Emergency #25

    Volgograd, Russia

  • Kursk city emergency hospital

    Kursk, Kursl Region, Russia

  • Sergiyev Posad Regional Clinical Hospital

    Sergiyev Posad, Moscow Oblast, Russia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.